The emerging importance of tranexamic acid in dermatology

被引：33

作者：

Forbat, E. ^{[1
]}

Ali, F. ^{[2
]}

Al-Niaimi, F. ^{[2
]}

机构：

[1] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Dermatol, Coventry, W Midlands, England

[2] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dermatol Surg & Laser Unit, London, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2020年 / 45卷 / 04期

关键词：

DOUBLE-BLIND; EFFICACY; HYPERPIGMENTATION; MELASMA; NIACINAMIDE; COMBINATION; SAFETY; LASER;

D O I：

10.1111/ced.14115

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Tranexamic acid (TA) is an antifibrinolytic agent, increasingly recognized as being of utility for a wide variety of skin diseases. We review the evidence supporting the use of TA for a range of dermatological indications, including (among others) melasma, postinflammatory hyperpigmentation, urticaria, angio-oedema and haemostasis, in addition to practical considerations of its use by dermatologists.

引用

页码：445 / 449

页数：5

共 30 条

[1] Therapeutic Effects of Topical Tranexamic Acid in Comparison with Hydroquinone in Treatment of Women with Melasma [J].

Atefi, Najmolsadat ;

Dalvand, Behzad ;

Ghassemi, Mahammadreza ;

Mehran, Golnaz ;

Heydarian, Amir .

DERMATOLOGY AND THERAPY, 2017, 7 (03) :417-424

[2] Tranexamic acid as first-line emergency treatment for episodes of bradykinin-mediated angioedema induced by ACE inhibitors [J].

Beauchene, C. ;

Martins-Hericher, J. ;

Denis, D. ;

Martin, L. ;

Maillard, H. .

REVUE DE MEDECINE INTERNE, 2018, 39 (10) :772-776

[3]

Budamakuntla Leelavathy, 2013, J Cutan Aesthet Surg, V6, P139, DOI 10.4103/0974-2077.118403

[4] Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation) [J].

Byun, Sang-Young ;

Chae, Je-Byeong ;

Na, Jung-Im ;

Park, Kyoung-Chan .

JOURNAL OF COSMETIC AND LASER THERAPY, 2016, 18 (05) :293-295

[5] Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma [J].

Del Rosario, Eunice ;

Florez-Pollack, Stephanie ;

Zapata, Lucio, Jr. ;

Hernandez, Katia ;

Tovar-Garza, Andrea ;

Rodrigues, Michelle ;

Hynan, Linda S. ;

Pandya, Amit G. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (02) :363-369

[6]

Desai S, 2019, J DRUGS DERMATOL, V18, P454

[7] Bradykinin: Inflammatory Product of the Coagulation System [J].

Hofman, Zonne ;

de Maat, Steven ;

Hack, C. Erik ;

Maas, Coen .

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2016, 51 (02) :152-161

[8] A Prospective Randomized Controlled Study of Oral Tranexamic Acid for Preventing Postinflammatory Hyperpigmentation After Q-Switched Ruby Laser [J].

Kato, Harunosuke ;

Araki, Jun ;

Eto, Hitomi ;

Doi, Kentaro ;

Hirai, Rintaro ;

Kuno, Shinichiro ;

Higashino, Takuya ;

Yoshimura, Kotaro .

DERMATOLOGIC SURGERY, 2011, 37 (05) :605-610

[9] A randomized, open-label, comparative study of oral tranexamic acid and tranexamic acid microinjections in patients with melasma [J].

Khurana, Vinod K. ;

Misri, Rachita R. ;

Agarwal, Swati ;

Thole, Akhilesh V. ;

Kumar, Sachin ;

Anand, Tanu .

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2019, 85 (01) :39-43

[10] Efficacy and possible mechanisms of topical tranexamic acid in melasma [J].

Kim, S. J. ;

Park, J. -Y. ;

Shibata, T. ;

Fujiwara, R. ;

Kang, H. Y. .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2016, 41 (05) :480-485

← 1 2 3 →